MW-559

N/A

Report date: 2023/05/06 11:13:41

Base Information

Drug NameMW-559
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus NS3 protein inhibitors
TargetsHepatitis C virus NS3 protein
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIrbm SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIrbm SPA
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A